Literature DB >> 18477999

Why do we need noncommercial, investigator-initiated clinical trials?

Alan Tyndall1.   

Abstract

Mesh：

Year:  2008        PMID： 18477999     DOI： 10.1038/ncprheum0814

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN： 1745-8382


× No keyword cloud information.
  4 in total

1.  [Basic principles, planning and implementation of non-commercial clinical trials].

Authors:  R P Finger; C Coch; M Coenen; M Mengel; G Hartmann; F G Holz
Journal:  Ophthalmologe       Date:  2011-01       Impact factor: 1.059

2.  Investigator-initiated pragmatic trials in developing countries--much needed but much ignored.

Authors:  Nusrat Shafiq; Promila Pandhi; Samir Malhotra
Journal:  Br J Clin Pharmacol       Date:  2008-11-03       Impact factor: 4.335

3.  Stem cell transplantation for autoimmune diseases.

Authors:  Thomas Hügle; Thomas Daikeler
Journal:  Haematologica       Date:  2010-02       Impact factor: 9.941

4.  Understanding the investigators: a qualitative study investigating the barriers and enablers to the implementation of local investigator-initiated clinical trials in Ethiopia.

Authors:  Samuel R P Franzen; Clare Chandler; Fikre Enquselassie; Sisira Siribaddana; Julius Atashili; Brian Angus; Trudie Lang
Journal:  BMJ Open       Date:  2013-11-27       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.